SHAPING THE FUTURE OF IMMUNOTHERAPY
ABOUT US
THIS IS SHAPE
Shape Biopharmaceuticals is a next-generation immunotherapy developer. With our ambitious team and network, we strive to create a new class of immunotherapeutic drugs for chronic human diseases with high unmet treatment needs, leveraging computational epitope-specific antigen design and next-generation nanoparticle engineering.
OUR FOCUS
WHAT WE DO
Optimizing Immunotherapy Design and Delivery
Antigen Engineering Technology
We employ leading-edge computational drug design and protein engineering technologies to optimize the immunological and antigenic properties of our target antigens.
Nano Formulation
We optimize the formulation using tailored nanoparticle-based delivery systems and specific immunomodulators to ensure optimal therapeutic responses in diverse patient populations.
ENABLING SMARTER EPITOPE-SPECIFIC IMMUNOTHERAPIES FOR PATIENTS
We are employing structurally defined, 3D optimized, engineered nanoparticle-based immunogens to produce personalized target epitope-specific therapeutic antibodies directly in patients leveraging their immune system.
To learn more about our current programs, please contact us here →
Registered Office in the U.S.:
- Shape Biopharmaceuticals Inc.
- 245 First St, Cambridge, MA 02142
- info@shapebiopharma.com
Registered Office in Switzerland:
- Shape Biopharmaceuticals GmbH
- Riedhofstrasse 11, 8804 Au ZH, Switzerland
- info@shapebiopharma.com